St. Olav University Hospital
Trondheim, 7006, Norway
NCT Number: NCT00218868
The purpose of this study is to compare and evaluate the diagnostic performance of scrape cytology using two different cytological staining techniques, and to evaluate additional touch imprint cytology with that of histopathology of superficial basal cell carcinoma and actinic keratosis.
Looking for future studies?
Notify Me0 year–105 year
All sexes
Observational
Trondheim, 7006, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Histologically verified basal call carcinoma and actinic keratosis
Exclusion criteria
Morphea form of basal cell carcinoma. Pigmented form of basal cell carcinoma.
scrape cytology using two different cytological staining techniques, and additional touch imprint cytology compared with histopathology of superficial basal cell carcinoma and actinic keratosis
Norwegian University of Science and Technology
Other
Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunvald-giemsa Stained Cutaneous Tissue Smear in Relation to Photodynamic Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01455363
Carcinoma, Carcinoma, Basal Cell
Paris, France
View Trial DetailsNCT05138328
Carcinoma, Carcinoma, Basal Cell
Detroit, Michigan, United States
View Trial DetailsNCT03897036
Carcinoma, Carcinoma, Basal Cell
Scottsdale, Arizona, United States
View Trial DetailsNCT03132636
Carcinoma, Carcinoma, Basal Cell
Phoenix, Arizona, United States
View Trial Details